Skip to content
Clinical Trials – home
RomaniaBack to Romania

Clinical trials in Focsani – page 2

14 clinical trials in Focsani, Romania. Every trial is listed in the EU Clinical Trials Register and updated daily.

RomaniaOur site in RomaniaStudii.Clinice.ro(opens in a new tab)
Focsani at a glance
14
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

14 trials in Focsani

Open in trial search

Major depression+1

Not recruiting

Study on Aticaprant and Antidepressant for Preventing Relapse in Adults with Major Depressive Disorder and Anhedonia

Investigational
Countries:RomaniaRomania
  • Participants:18–64 years
  • Substances:Aticaprant
  • Sponsor:Janssen Cilag International

Study on JTT-861 for Patients with Heart Failure with Reduced Ejection Fraction

Investigational
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:JTT-861 monohydrochloride dihydrate
  • Sponsor:Akros Pharma Inc.

Other cities in Romania

The busiest research cities in the country

All 63 cities in Romania

Clinical research in Focsani

What the registry says about research in the country

01 Depression and Mood Disorders

Clinical research focusing on Major Depressive Disorder (MDD) treatments, particularly examining innovative combination therapies for patients with specific symptoms.

  • MDD with Insomnia Symptoms
  • MDD with Moderate-to-severe Anhedonia
  • Adjunctive Therapy Approaches

These trials evaluate new therapeutic agents as add-ons to existing SSRI/SNRI antidepressants, aiming to improve treatment outcomes for patients with inadequate response to standard care.

02 Sleep-Related Mental Health

Investigating the relationship between sleep disorders and depression through targeted therapeutic interventions, specifically examining seltorexant's effectiveness in treating concurrent depression and insomnia.

  • Depression-Related Insomnia
  • Sleep-Mood Interaction
  • Symptom Management

Research focuses on both short-term symptom improvement and long-term relapse prevention strategies.

03 Treatment-Resistant Conditions

Studies examining novel approaches for patients with inadequate response to conventional antidepressant treatments, including the evaluation of aticaprant and seltorexant.

  • Relapse Prevention
  • Combination Therapy
  • Long-term Effectiveness

These trials aim to establish new therapeutic options for patients who don't achieve optimal results with standard treatments.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.